Introduction: Chronic pelvic and/or genital pain is a disabling condition and commonly associated with poor quality of life, impaired sexual function, and decreased productivity.
Methods: A series of within-subject ANOVAs (corrected for multiple comparisons) were used to evaluate the effectiveness of an Interdisciplinary Pain Rehabilitation Program (IPRP) on self-reported (pain severity, interference, depressive symptoms, quality of life) and observer-rated outcomes (5-minute walk) among 15 patients receiving care at the Mayo Clinic IPRP between 2016-2018. Additionally, opioid use of participants was assessed throughout the program via total daily Morphine Milligram Equivalents (MME).
Results: Fifteen patients (5 male, 10 female) were identified. Mean age was 47.0 (range: 24-78) and primary diagnoses were pelvic pain (n=13) and penile pain (n=2). Significant within-subject effects were detected for all self-report outcomes and the 5-minute walk test (Table 1). Six patients were on opioid therapy (MME = 49mg), and all but one successfully tapered off opioids. In the remaining patient, daily MME decreased from 150 mg to 30 mg (Figure 1).
Conclusions: Intensive outpatient IPRP significantly improves quality of life for patients with treatment-refractory chronic pelvic and/or genital pain. These results support multi-disciplinary treatment paradigms for refractory urogenital pain.
.jpg)
.jpg)
